ADHERON THERAPEUTICS
Adheron Therapeutics was established in 2006 as Synovex Corporation. The company’s therapeutic program is based on pioneering work done in the laboratory of Dr. Michael Brenner at Brigham and Women’s Hospital and Harvard Medical School. Dr. Brenner discovered that Cadherin-11 (Cad-11) acts as an “adhesive’ between cells and hanges in these Cad-11 interactions can induce the cells to produce many proteins that influence the cellular environment positively or adversely. Based on this discovery, Adheron is developing a best-in-class antibody tackling a variety of diseases by disrupting the adhesion of cells.
ADHERON THERAPEUTICS
Social Links:
Industry:
Biotechnology Pharmaceutical Therapeutics
Founded:
2003-01-01
Address:
Berkeley, California, United States
Country:
United States
Website Url:
http://www.adherontherapeutics.com
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
1.5 M USD
Technology used in webpage:
Domain Not Resolving Mobile Non Scaleable Content Nginx 1.16
Similar Organizations
Aclaris Therapeutics
Aclaris Therapeutics is a specialty pharmaceutical company engaged in developing dermatologic therapies.
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
AZTherapies
AZTherapies is a clinical stage biotech company developing breakthrough treatments for neuroinflammation-related diseases.
Imvax
Imvax is a biotechnology company focused on the development of novel patient-specific vaccines and immunotherapy strategies.
Inovio Pharmaceuticals
Inovio is a biotech company focusing on bringing to market DNA medicines for diseases associated with HPV, cancer, and infectious diseases.
Provenance Biopharmaceuticals
Provenance is a biotechnology company focused on developing therapeutics for life-threatening diseases using its antibody technologies.
Sonnet BioTherapeutics
Sonnet BioTherapeutics is a biotechnology company for innovating biologic drugs of the single or bispecific mechanism of action.
Current Advisors List
Current Employees Featured
Founder
Official Site Inspections
http://www.adherontherapeutics.com
- Host name: 162.255.119.136
- IP address: 162.255.119.136
- Location: Los Angeles United States
- Latitude: 34.0318
- Longitude: -118.4252
- Metro Code: 803
- Timezone: America/Los_Angeles
- Postal: 90064
More informations about "Adheron Therapeutics"
Adheron Therapeutics - Crunchbase Company Profile & Funding
Adheron Therapeutics was established in 2006 as Synovex Corporation. The company’s therapeutic program is based on pioneering work done in the laboratory of Dr. Michael …See details»
Adheron Therapeutics - PitchBook
Adheron Therapeutics General Information Description. Developer of Cadherin-11 antagonists for the treatment of rheumatoid arthritis and fibrotic diseases including pulmonary fibrosis and skin …See details»
Adheron Therapeutics, Inc. - Drug pipelines, Patents, Clinical trials ...
Explore Adheron Therapeutics, Inc. with its drug pipeline, therapeutic area, technology platform, 1 news, Drug:RG-6125.See details»
Adheron Therapeutics - VentureRadar
Website: http://adherontherapeutics.com/ Adheron Therapeutics is a biotechnology company focused on leveraging pioneering technology that disrupts cell adhesion to ...See details»
Adheron Therapeutics - Contacts, Employees, Board Members, …
Adheron is a biotechnology company focused on leveraging pioneering technology that disrupts cell adhesion to treat a variety of diseases.See details»
Adheron Therapeutics - VentureRadar
Similar Companies: Sonoma Therapeutics USA Privately Held Sonoma Biotherapeutics is an immune tolerance company developing engineered regulatory T cell (Treg) therapies to treat …See details»
Adheron Therapeutics - Ownership and Business Overview - Mergr
Oct 9, 2015 Out of 60 sectors in the Mergr database, life science ranked 7 in number of deals in 2015.The largest life science acquisition in 2015 was Allergan - which was acquired by …See details»
Adheron Therapeutics - Company Profile - Tracxn
Nov 27, 2024 Adheron is a company focused on leveraging pioneering technology that disrupts cell adhesion to treat a varietyof diseases. Adheron Therapeutics has developed a pioneering …See details»
Roche acquires Adheron Therapeutics - 2015-10-07 - Crunchbase
Oct 7, 2015 Acquired Organization: Adheron Therapeutics Adheron is a biotechnology company focused on leveraging pioneering technology that disrupts cell adhesion to treat a variety of …See details»
Adheron Therapeutics, Inc.:Company Profile & Technical Research ...
Adheron Therapeutics, Inc. is a company that provides Pulmonary fibrosis, Fibrosis, Rheumatoid arthritis and more. Adheron Therapeutics, Inc. is headquartered in United States California.See details»
Adheron Therapeutics | CipherBio
Explore Adheron Therapeutics's investment information, scientific platforms, therapeutic approaches, indications and more here!See details»
Adheron Therapeutics - Products, Competitors, Financials, …
Headquarters Location. 2930 Domingo Ave. Berkeley, California, 94705, United States. 858-926-8155See details»
Adheron Therapeutics Inc. - BioCentury Company Profiles - BCIQ
Jul 24, 2020 Adheron Therapeutics Inc. - BioCentury Company Profiles for the biopharma industrySee details»
Adheron Therapeutics, Inc. - Company Profile & Staff Directory
Adheron Therapeutics, Inc. is a biotechnology company based out of Vico San Pancrazio, Genoa, Liguria, Italy.See details»
Adheron Therapeutics to be acquired by Roche - Borderless
Adheron Therapeutics, a privately held biotechnology company based in Berkeley, California, United States, announced today that it has agreed to be acquired by Roche. Adheron …See details»
Roche acquires Adheron Therapeutics to strengthen pipeline in ...
Health Organization Model Lists of Essential Medicines, among them life -saving antibiotics, antimalarials and chemotherapy. In 2014, the Roche Group employed 88,500 people …See details»
Adheron Therapeutics CEO, Founder, Key Executive Team, Board of ...
Explore {Adheron Therapeutics's key management people. Discover current leadership team members including founders, CEO, other executives and board directors.See details»
Roche agrees to buy US biotech Adheron for $580m
Oct 11, 2015 Swiss drug manufacturer Roche has agreed to acquire US biotechnology firm Adheron Therapeutics for $580m to expand its drug portfolio to treat inflammatory and …See details»
Roche Acquires Adheron Therapeutics for up to $580M
Oct 12, 2015 The deal will expand Roche's portfolio of products to treat diseases like rheumatoid arthritisSee details»
Adheron Therapeutics Announces Favorable Phase 1 Clinical Trial …
Jan 8, 2014 San Francisco, CA /PRNewswire/ - Adheron Therapeutics, a biotechnology company which focuses on leveraging pioneering technology that disrupts cell adhesion to …See details»